Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients.
Front Immunol. 2016 Dec 26;7:648. doi: 10.3389/fimmu.2016.00648. eCollection 2016.
Front Immunol. 2016.
PMID: 28082983
Free PMC article.
Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cells.
Klaver Y, van Steenbergen SCL, Sleijfer S, Debets R, Lamers CHJ.
Klaver Y, et al. Among authors: van steenbergen scl.
Clin Immunol. 2016 Aug;169:107-113. doi: 10.1016/j.clim.2016.06.014. Epub 2016 Jul 1.
Clin Immunol. 2016.
PMID: 27377533
Item in Clipboard
Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells.
Lamers CH, van Elzakker P, van Steenbergen SC, Luider BA, Groot C, van Krimpen BA, Vulto A, Sleijfer S, Debets R, Gratama JW.
Lamers CH, et al. Among authors: van steenbergen sc.
Cytotherapy. 2013 May;15(5):620-6. doi: 10.1016/j.jcyt.2012.12.006. Epub 2013 Feb 4.
Cytotherapy. 2013.
PMID: 23388583
Clinical Trial.
Item in Clipboard
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.
Straetemans T, van Brakel M, van Steenbergen S, Broertjes M, Drexhage J, Hegmans J, Lambrecht BN, Lamers C, van Der Bruggen P, Coulie PG, Debets R.
Straetemans T, et al.
Clin Dev Immunol. 2012;2012:586314. doi: 10.1155/2012/586314. Epub 2012 Feb 12.
Clin Dev Immunol. 2012.
PMID: 22400038
Free PMC article.
Item in Clipboard
Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.
Lamers CH, Sleijfer S, van Steenbergen S, van Elzakker P, van Krimpen B, Groot C, Vulto A, den Bakker M, Oosterwijk E, Debets R, Gratama JW.
Lamers CH, et al.
Mol Ther. 2013 Apr;21(4):904-12. doi: 10.1038/mt.2013.17. Epub 2013 Feb 19.
Mol Ther. 2013.
PMID: 23423337
Free PMC article.
Clinical Trial.
Item in Clipboard
Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
Lamers CH, van Elzakker P, van Steenbergen SC, Sleijfer S, Debets R, Gratama JW.
Lamers CH, et al. Among authors: van steenbergen sc.
Cytotherapy. 2008;10(4):406-16. doi: 10.1080/14653240801982961.
Cytotherapy. 2008.
PMID: 18574773
Item in Clipboard
Retroviral vectors for clinical immunogene therapy are stable for up to 9 years.
Lamers CH, van Elzakker P, Luider BA, van Steenbergen SC, Sleijfer S, Debets R, Gratama JW.
Lamers CH, et al. Among authors: van steenbergen sc.
Cancer Gene Ther. 2008 Apr;15(4):268-74. doi: 10.1038/sj.cgt.7701114. Epub 2008 Jan 18.
Cancer Gene Ther. 2008.
PMID: 18202714
Item in Clipboard
Cite
Cite